HHS scheme for access to real-time Rx drug price information

3 September 2025

The US Department of Health and Human Services (HHS) yesterday announced prescription drug reforms are set to take effect October 1, designed to give patients and physicians real-time access to prescription drug costs, insurance coverage details and prior authorization requirements.

The reform will help them identify the most appropriate, cost-effective treatments while preventing health insurers from blocking physician-approved care. Thanks to this rule change, millions of Americans for the first time will be able to compare drug prices, view out-of-pocket costs, and access prior authorization requirements, the HHS statement noted.

The HHS’ final rule ensures that health care providers using certified health IT systems are able to submit prior authorizations electronically, select drugs consistent with a patient’s insurance coverage, and exchange electronic prescription information with pharmacies and insurance plans.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight



More Features in Pharmaceutical